title: Editorial comment to Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: a randomized double-blind trial.
authors.affiliation: Department of Urology, Loma Linda University, Loma Linda, California, USA. drjavee@yahoo.com.
authors.forename: Javier L
authors.initials: JL
authors.lastname: Arenas
authors.forename: D Duane
authors.initials: DD
authors.lastname: Baldwin
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage*; D018727:Muscarinic Antagonists / Q000008:administration & dosage*
chemical_list: D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin